Perspective Therapeutics, Inc. (CATX) Reports Positive Results for NET Treatment Trial
Perspective Therapeutics, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Marshall Wace LLP Paul Marshall And Ian Wace | 520,707 | $1,791,231 | -55% | 0% |
2. | Walleye Capital Will England | 187,403 | $644,666 | +376% | 0% |
3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.21 | 4,650 | $10,288.13 | 4,650 | 2025-03-28 | Filing | |
$2.24 | 22,026 | $49,384.49 | 59,383 | 2025-03-28 | Filing | |
$2.14 | 38,145 | $81,775.25 | 108,982 | 2025-03-31 | Filing | |
$2.27 | 22,192 | $50,375.84 | 70,837 | 2025-03-28 | Filing | |
$2.25 | 33,333 | $74,945.92 | 35,354 | 2025-03-28 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.53 | 13,340 | $20,410.20 | 0 | 2015-04-02 | Filing | |
$2.54 | 25,000 | $63,560.00 | 0 | 2014-06-10 | Filing | |
$2.27 | 25,000 | $56,750.00 | 0 | 2014-06-03 | Filing | |
$2.22 | 30,571 | $67,867.62 | 0 | 2014-05-27 | Filing | |
$2.22 | 30,571 | $67,867.62 | 0 | 2014-05-27 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 4,294,151 | $14,771,880 | 0% | |
2. | 3,274,333 | $11,263,706 | 0% | |
3. | 2,297,314 | $7,902,760 | 0% | |
4. | 1,614,283 | $5,553,134 | 3.42% | |
5. | 1,382,814 | $4,757,780 | 0% |